David C. Young at University of Utah Health - Research Interests, Publications & Academic Profile

David C. Young

University of Utah Health

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Continue in dashboard

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

60%

Pharmacy

100%

Antibiotic Therapy

70%

Cystic Fibrosis Research

50%

Therapeutic Drug Monitoring

40%

Fluid Therapy

40%

Pharmacoepidemiology

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis

Article Link

Year:

2024

A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis

Article Link

Year:

2024

A decade of change: The evolution of pharmacy services at U.S. cystic fibrosis centers

Article Link

Year:

2024

Venous thromboembolism management in people with cystic fibrosis

Article Link

Year:

2024

The pharmacokinetics and pharmacodynamics of continuous infusion vancomycin in adult people with cystic fibrosis

Article Link

Year:

2024

International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists

Article Link

Year:

2023

International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary

Article Link

Year:

2023

Effective pharmacy provider handoff communication for transition of patient care in CF

Article Link

Year:

2023

Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis

Article Link

Year:

2022

The indispensable role of pharmacy services and medication therapy management in cystic fibrosis

Article Link

Year:

2022

Collaborators4

Lisa Hong

Associate Profesor

Loma Linda University School of Pharmacy

UNITED STATES

View Details

Mohammad Alshaer

University of Florida Health

UNITED STATES

View Details

Robert Bonomo

Case Western Reserve University

UNITED STATES

View Details

VENKATA YELLEPEDDI

Associate Professor

University of Utah

UNITED STATES

View Details

How do I reach out?

Continue in dashboard